Ratings Siemens Healthineers AG Wiener Boerse

Equities

SHL

DE000SHL1006

End-of-day quote Wiener Boerse Other stock markets 06:00:00 2024-05-28 pm EDT			5-day change	1st Jan Change
53.8 ^EUR	-0.19%		+0.15%	+2.01%

May. 23	Ailing hospitals slow down German medical technology sector	DP
May. 22	SIEMENS HEALTHINEERS : Berenberg maintains a Buy rating	ZD

Strengths

Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Over the past twelve months, analysts' opinions have been strongly revised upwards.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
The group usually releases upbeat results with huge surprise rates.

Weaknesses

The company is in debt and has limited leeway for investment
With a 2024 P/E ratio at 29.71 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
The company's enterprise value to sales, at 3.15 times its current sales, is high.
In relation to the value of its tangible assets, the company's valuation appears relatively high.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

	1st Jan change	Capi.	ESG Refinitiv
SIEMENS HEALTHINEERS AG	+2.01%	64.68B	-
THERMO FISHER SCIENTIFIC	+6.02%	215B	B
DANAHER CORPORATION	+9.25%	187B	B-
INTUITIVE SURGICAL, INC.	+19.58%	143B	B-
BOSTON SCIENTIFIC CORPORATION	+29.74%	110B	A-
EDWARDS LIFESCIENCES CORPORATION	+15.27%	52.96B	B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+2.69%	49.84B	B+
AGILENT TECHNOLOGIES, INC.	-5.47%	38.32B	A
GE HEALTHCARE TECHNOLOGIES INC.	+1.58%	35.86B	-
RESMED, INC.	+21.70%	30.75B	B+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes